Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.44%Debt Paydown Yield
VS
Market
Sector
Industry
History
$ 1.29Close
$ 0.45 - $ 2.21 52-Week Range
Ticker Information
Ticker
KAPACompany Name
KAIROS PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTKAIROS PHARMA LTD - Debt Paydown Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KAPA - Debt Paydown Yield Historical data
| Date | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
|---|---|---|---|
| 6/30/2025 | 0.44% | $ 23.23M | $ -102K |
| 3/31/2025 | 0% | $ 10.45M | $ 0 |
| 12/31/2024 | 0% | $ 16.43M | $ 0 |
| 9/30/2024 | -0.54% | $ 26.4M | $ 142K |
| 12/31/2023 | 0% | $ 0 | $ 0 |
| 12/31/2022 | 0% | $ 0 | $ 774K |
Key Performance Insights, Last 5 Years
- KAIROS PHARMA LTD's latest trailing twelve months (TTM) Debt Paydown Yield stands at 0%.
- Over the past 5 years, KAIROS PHARMA LTD's average Debt Paydown Yield has been -0.02%.
- The median Debt Paydown Yield for KAIROS PHARMA LTD during this period was 0%
- KAIROS PHARMA LTD reached its highest Debt Paydown Yield over the past 5 years at 0.44%.
- The lowest Debt Paydown Yield recorded by KAIROS PHARMA LTD in the same timeframe -0.54%
Similar metrics to CF - Debt:
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
Definition of Debt Paydown Yield
[Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield Debt Paydown Yield for KAIROS PHARMA LTD is calculated as follows: (-1 * CF - Debt [ $ 774K ]) / Market Cap [ $ 0 ]
(=) Debt Paydown Yield [ 0% ] KAPA - Debt Paydown Yield, Last 5 years
-0.54%
Minimum
Sep 30, 2024
0.44%
Maximum
Jun 30, 2025
-0.02%
Average
0%
Median
Debt Paydown Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Debt Paydown Yield for companies in the Total Stock Market. The average Debt Paydown Yield of the companies is -0.08% with a standard deviation of 3.82%.
The following table provides additional summary stats:
Debt Paydown Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -11.5% |
| max | 11.49% |
| average | -0.08% |
| median | 0% |
| std | 3.82% |